Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haotian Wei

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Urologic Oncology|March 28, 2025
The fragility index of randomized controlled trials in advanced/metastatic renal cell cancerYingwei Bi, Haotian Wei, Qifeng Ma, et al.
Scientific Reports|April 19, 2025
The role of adherent-to-suspension transition factors in clear cell renal cell carcinoma progression: a comprehensive analysisChenglong Xu, Haotian Wei, Yue Wang, et al.
Current Pharmaceutical Design|June 20, 2022
Identification of Neural Progenitor Cell-associated Chemoradiotherapy Resistance Gene Set (<i>ARL4C, MSN, TNFAIP6</i>) for Prognosis of GliomaYongchang Yang, Xing Xu, Yang Xie, et al.
Theranostics|July 12, 2024
The CEBPB<sup>+</sup> glioblastoma subcluster specifically drives the formation of M2 tumor-associated macrophages to promote malignancy growthYongchang Yang, Xingyu Jin, Yang Xie, et al.
Molecular Cancer|May 1, 2026
A non-complement role for C1R rewires integrin and death-receptor signaling to drive renal cancer metastasisHaotian Wei, Shenglong Li, Shimiao Zhu, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Urologic Oncology|March 28, 2025
The fragility index of randomized controlled trials in advanced/metastatic renal cell cancerYingwei Bi, Haotian Wei, Qifeng Ma, et al.
Scientific Reports|April 19, 2025
The role of adherent-to-suspension transition factors in clear cell renal cell carcinoma progression: a comprehensive analysisChenglong Xu, Haotian Wei, Yue Wang, et al.
Current Pharmaceutical Design|June 20, 2022
Identification of Neural Progenitor Cell-associated Chemoradiotherapy Resistance Gene Set (<i>ARL4C, MSN, TNFAIP6</i>) for Prognosis of GliomaYongchang Yang, Xing Xu, Yang Xie, et al.
Theranostics|July 12, 2024
The CEBPB<sup>+</sup> glioblastoma subcluster specifically drives the formation of M2 tumor-associated macrophages to promote malignancy growthYongchang Yang, Xingyu Jin, Yang Xie, et al.
Molecular Cancer|May 1, 2026
A non-complement role for C1R rewires integrin and death-receptor signaling to drive renal cancer metastasisHaotian Wei, Shenglong Li, Shimiao Zhu, et al.
Pageof 3